Knight Therapeutics (04K.F) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.01
0.01
0.04
0.07

Details

Expected EPS
0.003354669037256
Actual EPS
0.012378852536
Surprise EPS
0.01
Surprise Percent
+269%

Description

Knight Therapeutics (04K.F) has reported earnings of 0.012378852536 per share for Q2 2025.

0 Comments

Share your thoughts